Abstract
The principle of basing medical decisions on the concept of risk is not new. Table 1 shows comparative information on medical management guidance in a number of relatively common scenarios such as the use of statins in hypercholesterolaemia, treatment of hypertension, prevention of sudden death in hypertrophic cardiomyopathy, prevention of berry aneurysm rupture in autosomal dominant polycystic kidney disease, screening for Down Syndrome in pregnancy and the management of familial breast cancer susceptibility (Table 1).
Highlights
In an economic climate of limited resources alongside technological advances and rising patient expectations, there are new challenges to the implementation of preventative medicine
This paper debates the dawn of personalised health care through genomic medicine, the challenges this creates when applied to existing health systems and straight-to-consumer testing
The vision of genomic medicine is that screening, preventative health care and prescribing choices and initial dosage decision making
Summary
Received date: October 28, 2015; Accepted date: November 18, 2015; Published date: November 21, 2015. Health care would be based on an individual's calculated risk rather than empirical evidence
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
